Dietary GD3 ganglioside reduces the incidence and severity of necrotizing enterocolitis by sustaining regulatory immune responses

Journal of Pediatric Gastroenterology and Nutrition

Volumn 57, Issue 5, 2013, Pages 550-556

  Xu, Jiliu ^a   Anderson, Virginia ^b   Schwarz, Steven M ^a  

^a Division of Gastroenterology and Hepatology   (United States)

^b SUNY Downstate Medical Center   (United States)

Author keywords

chemokine; cytokine; Foxp3; ganglioside; GD3; ileum

Indexed keywords

CHEMOKINE; CYTOKINE; GANGLIOSIDE GD3; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MILK; ASPHYXIA; COLD STRESS; CONTROLLED STUDY; DISEASE SEVERITY; HISTOPATHOLOGY; ILEUM; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INCIDENCE; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; UPREGULATION; WEIGHT GAIN;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CELL COUNT; COLOSTRUM; CYTOKINES; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; ENTEROCOLITIS, NECROTIZING; FORKHEAD TRANSCRIPTION FACTORS; GANGLIOSIDES; ILEUM; IMMUNOLOGIC FACTORS; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 84888133687     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182a027e1     Document Type: Article

References (45)

1. Guthrie SO, Gordon PV, Thomas V, et al. Necrotizing enterocolitis among neonates in the United States. J Perinatol 2003;23:278-85
2. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364:255e64
3. Caplan MS, MacKendrick W. Necrotizing enterocolitis: A review of pathogenetic mechanisms and implications for prevention. Pediatr Pathol 1993;13:357-69
4. Nanthakumar N, Meng D, Goldstein AM, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: An immature innate immune response. PLoS One 2011;6:e17776
5. Weitkamp J-H, Koyama T, Rock MT, et al. Necrotizing enterocolitis is characterized by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut 2013;62: 173-82
6. Afrazi A, Sodhi CP, Richardson W, et al. New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond. Pediatr Res 2011;69:183-8
7. Buescher ES. Host defense mechanisms of human milk and their relations to enteric infections and necrotizing enterocolitis. Clin Perinatol 1994;21:247-62
8. Hanson LA. Breastfeeding provides passive and likely long-lasting active immunity. Ann Allergy Asthma Immunol 1998;81:523-33
9. Walker WA. Breast milk and the prevention of neonatal and preterm gastrointestinal disease states: A new perspective. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1997;38:321-31
10. Schnabl KL, Larsen B, Van Aerde JE, et al. Gangliosides protect bowel in an infant model of necrotizing enterocolitis by suppressing proinflammatory signals. J Pediatr Gastroenterol Nutr 2009;49:382-92
11. Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 1990;265:18713-6
12. Ledeen RW. Biosynthesis, metabolism and biological effects of gangliosides. In: Margolis RU, Margolis RK, eds. Neurobiology of Glycoconjugates. New York: Plenum Press; 1989:43-8
13. Merrill AH Jr, Schmelz EM, Dillehay DL, et al. Sphingolipids-The enigmatic lipid class: Biochemistry, physiology and pathophysiology. Toxicol Appl Pharmacol 1997;142:208-25
14. Pan XL, Izumi T. Variation of the ganglioside compositions of human milk, cow's milk and infant formulas. Early Hum Devel 2000;57:25-31
15. Draper JS, Pigott C, Thomson JA, et al. Surface antigens of human embryonic stem cells: Changes upon differentiation in culture. J Anat 2002;200:249-58
16. Ravindranath MH, Tsuchida T, Morton DL, et al. Ganglioside GM3:GD3 ratio as an index for the management of melanoma. Cancer 1991;67:3029-35
17. Park EJ, Suh M, Thomson B, et al. Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains. Glycobiology 2005;15:935-42
18. Dvorak B, Khailova L, Clark JA, et al. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 2008;47:11-8
19. Dvorak B, Halpern MD, Holubec H, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002;282:G156-64
20. Claud EC, Lu L, Anton PM, et al. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellininduced inflammation. Proc Natl Acad Sci U S A 2004;101:7404-8
21. Otte JM, Podolsky DK. Functional modulation of enterocytes by grampositive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004;286:G613-26
22. Abreu MT. The Ying and Yang of bacterial signaling in necrotizing enterocolitis. Gastroenterology 2010;138:39-43
23. Miklavcic JJ, Schnabl KL, Mazurak VC, et al. Dietary ganglioside reduces proinflammatory signaling in the intestine. J Nutr Metab 2012;2012:280286
24. Park EJ, Suh M, Thomson B, et al. Dietary ganglioside inhibits acute inflammatory signals in intestinal mucosa and blood induced by systemic inflammation of Escherichia coli lipopolysaccharide. Shock 2007;28:112-7
25. Crespo FA, Sun X, Cripps JG, et al. The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses. J Leukoc Biol 2006;79:586-95
26. Park EJ, Thomson AB, Clandinin MT. Protection of intestinal occludin tight junction protein by dietary gangliosides in lipopolysaccharideinduced acute inflammation. J Pediatr Gastroenterol Nutr 2010;50: 321-8
27. Murai1 M, Turovskaya1 O, Kim G, et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009;10:1178-84
28. Frost BL, Jilling T, Caplan MS, et al. The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. Semin Perinatol 2008;32:100-6
29. Harris MC, Costarino AT Jr, Sullivan JS, et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 1994;124:105-11
30. Fituch CC, Palkowetz KH, Goldman AS, et al. Concentrations of IL-10 in preterm human milk and in milk from mothers of infants with necrotizing enterocolitis. Acta Paediatr 2004;93:1496-500
31. Dvorak B, Halpern MD, Holubec H, et al. Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model. Pediatr Res 2003;53:426-33
32. Xu J, Treem WR, Roman C, et al. Ileal immune dysregulation in necrotizing enterocolitis: Role of CD40/CD40L in the pathogenesis of disease. J Pediatr Gastroenterol Nutr 2011;52:140-6
33. Mathur RK, Awasthi A, Wadhone P, et al. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 2004;10:540-4
34. Murugaiyan G, Agrawal R, Mishra GC, et al. Functional dichotomy in CD40 reciprocally regulates effector T cell functions. J Immunol 2006;177:6642-9
35. González-Cortés C, Diez-Tascón C, Guerra-Laso JM, et al. Nonchemotactic influence of CXCL7 on human phagocytes. Modulation of antimicrobial activity against L. pneumophila. Immunobiology 2012; 217:394-401
36. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999;103 (4 pt 1):766-71
37. Pender SL, Braegger C, Gunther U, et al. Matrix metalloproteinases in necrotising enterocolitis. Pediatr Res 2003;54:160-4
38. Bister V, Salmela MT, Heikkilä P, et al. Matrilysins-1 and -2 (MMP-7 and -26) and metalloelastase (MMP-12), unlike MMP-19, are upregulated in necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 2005; 40:60-6
39. Lubetzky R, Mandel D, Mimouni FB, et al. MMP-2 and MMP-9 and their tissue inhibitor in preterm human milk. J Pediatr Gastroenterol Nutr 2010;51:210-2
40. Subramanian H, Grailer JJ, Ohlrich KC, et al. Signaling through L-selectin mediates enhanced chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine. J Immunol 2012;188:3223-36
41. Weil BR, Markel TA, Herrmann JL, et al. Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms. Surgery 2009;146:190-7
42. Romagnoli C, Frezza S, Cingolani A, et al. Plasma levels of interleukin- 6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 2001;160:345-50
43. Halpern MD, Clark JA, Saunders TA, et al. Reduction of experimental necrotizing enterocolitis with anti-TNF-Alpha. Am J Physiol Gastrointest Liver Physiol 2006;290:G757-64
44. Bode L, Beermann C, Mank M, et al. Human and bovine milk gangliosides differ in their fatty acid composition. J Nutr 2004;134:3016-20
45. Schnabl KL, Larcelet M, et al. Thomson AB, et al. Uptake and fate of ganglioside GD3 in human intestinal Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 2009;297:G52-9.